The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Pfizer naming Deirdre Gillane .

Filed returns
24
match these filters
Matching filed returns per period 0 1 2 3 5 Jan–Apr 2021: 3 filed returns May–Aug 2021: 2 filed returns Sep–Dec 2021: 2 filed returns Jan–Apr 2022: 1 filed returns May–Aug 2022: 2 filed returns Sep–Dec 2022: 4 filed returns Jan–Apr 2023: 2 filed returns Sep–Dec 2023: 1 filed returns May–Aug 2024: 1 filed returns Sep–Dec 2024: 2 filed returns Jan–Apr 2025: 2 filed returns May–Aug 2025: 1 filed returns Jan–Apr 2026: 1 filed returns 2021 2022 2023 2025 2026
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
Jan–Apr 2026 Pfizer Health Expansion of the National Immunisation Programme to include RSV vaccination for older adults (Public policy or programme) 16 On lobbying.ie
May–Aug 2025 Pfizer Trade Raise concern about the impact of potential tariffs and related geo-political issues related to the pharmaceutical industry and pricing of medicines globally (Public policy or programme) 11 On lobbying.ie
Jan–Apr 2025 Pfizer Trade Raise concern about the impact of potential tariffs on pharmaceutical manufacturing and supply of medicines to patients globally (Public policy or programme) 11 On lobbying.ie
Jan–Apr 2025 Pfizer EU Affairs EU Pharmaceutical Legislation proposals (Legislation) 7 On lobbying.ie
Sep–Dec 2024 Pfizer Economic Development and Industry Life Science Strategy and Industrial Policy (Public policy or programme) 8 On lobbying.ie
Sep–Dec 2024 Pfizer Health Ireland's medicine reimbursement system and funding for access to new medicines and vaccines (Matters involving public funds) 15 On lobbying.ie
May–Aug 2024 Pfizer EU Affairs EU Pharmaceutical Legislation proposals (Legislation) 14 On lobbying.ie
Sep–Dec 2023 Pfizer Health Ireland's medicine reimbursement system and Budget funding for new medicines (Matters involving public funds) 9 On lobbying.ie
Jan–Apr 2023 Pfizer Economic Development and Industry Pfizer recent 1.2 billion euro investment in Ireland operations creating 400-500 jobs (Public policy or programme) 13 On lobbying.ie
Jan–Apr 2023 Pfizer EU Affairs EC HERA contract in relation to Pfizer COVID-19 vaccine (Matters involving public funds) 5 On lobbying.ie
Sep–Dec 2022 Pfizer EU Affairs EC HERA contract in relation to Pfizer COVID-19 vaccine (Matters involving public funds) 5 On lobbying.ie
Sep–Dec 2022 Pfizer Energy and Natural Resources Potential energy shortages (Public policy or programme) 7 On lobbying.ie
Sep–Dec 2022 Pfizer Budgetary matters Budget 2023 (Public policy or programme) 8 On lobbying.ie
Sep–Dec 2022 Pfizer Economic Development and Industry COVID-19 Trips waiver - vaccines and therapeutics (Public policy or programme) 7 On lobbying.ie
May–Aug 2022 Pfizer Budgetary matters Budget 2023 (Public policy or programme) 9 On lobbying.ie
May–Aug 2022 Pfizer Health COVID-19 vaccination programme (Public policy or programme) 4 On lobbying.ie
Jan–Apr 2022 Pfizer Health Update on Pfizer COVID 19 antiviral treatment and processes in ensuring availability of the treatment in Ireland (Matters involving public funds) 2 On lobbying.ie
Sep–Dec 2021 Pfizer Health COVID-19 vaccination programme (Public policy or programme) 5 On lobbying.ie
Sep–Dec 2021 Pfizer Health Pfizer has an investigational COVID-19 treatment, a protease inhibitor which subject to clinical trials and regulatory approvals could play a complementary role to vaccination in helping to manage COVID-19 (Matters involving public funds) 5 On lobbying.ie
May–Aug 2021 Pfizer Health Supply of Pfizer COVID-19 vaccine including Ireland volumes; expansion of manufacturing capacity to include Grange Castle site and Pfizer colleague vaccination programme (Public policy or programme) 8 On lobbying.ie
May–Aug 2021 Pfizer Economic Development and Industry Globally, debate is underway in relation to a COVID-19 vaccines IP waiver (Public policy or programme) 2 On lobbying.ie
Jan–Apr 2021 Pfizer Economic Development and Industry Highlight the importance of pharmaceutical manufacturing activity being deemed essential activity to ensure the continued operation of Pfizer manufacturing sites wh (Public policy or programme) 2 On lobbying.ie
Jan–Apr 2021 Pfizer EU Affairs Highlight Pfizer concerns re proposed EU vaccine export restrictions and how this could impact Pfizer's ability to manufacture the COVID 19 vaccine and provide supply globally (Public policy or programme) 5 On lobbying.ie
Jan–Apr 2021 Pfizer Health Updates in relation to Pfizer COVID 19 vaccine including global production, Ireland volumes and company colleague vaccination programme (Matters involving public funds) 10 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 9 37.5%
EU Affairs 5 20.8%
Economic Development and Industry 5 20.8%
Budgetary matters 2 8.3%
Trade 2 8.3%
Energy and Natural Resources 1 4.2%